OMX30 1 570 -1,2%  OMXH25 3 712 -0,7%  OMXC20 912 -0,8%  Dow 20 822 0,1%  Nas 5 343 0,2%  EUR 9,5453 0,0%  USD 9,0368 0,0%  Olja 56,0 -0,8%  Guld 1 257 0,6% 

Baxter International Aktie

50,49USD 0,08USD 0,16%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Baxter International

2016 2017e 2018e 2019e 2020e
Utdelning 0,50 0,58 0,61 0,67 0,80
Direktavkastning (i %) 1,15 1,29 1,36 1,50 1,79
PE-tal 22,22 20,68 18,28 16,23 14,52
Resultat/aktie 1,96 2,16 2,45 2,76 3,08

Nyheter om Baxter International Inc.

ytterligare nyheter

Analyser om Baxter International Inc.

ytterligare analyser

Baxter International Peer Group

Baxter International 50,49
0,2%
Boston Scientific 24,78
1,2%
Cardinal Health 82,12
0,5%
Fresenius Medical Care 77,66
-1,3%
Fresenius 75,67
-1,2%
Medtronic 81,02
0,3%
STRATEC Biomedical 46,55
-2,8%
pagehit

Lägg till instrument

Vad tycker du?

Profil Baxter International Inc.

till bolagsprofilen
Baxter International, Inc. provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctor's offices and by patients at home under physician supervision. It operates through the following segments: Hospital Products and Renal. The Hospital Products segment intravenous IV solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, inhalation anesthetics, and biosurgery products. This segment also provides products and services related to pharmacy compounding, drug formulation. The Renal segment provides products and services to treat end-stage renal disease, or irreversible kidney failure and acute kidney injuries. This segment offers a comprehensive portfolio to meet the needs of patients across the treatment continuum, including technologies and therapies for peritoneal dialysis, in-center hemodialysis, home HD, continuous renal replacement therapy and additional dialysis services. Baxter International was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Realtidskurs Baxter International Inc.

Bid
50,49
USD
Ask
50,50
USD
Kurstid
21:59
Börsen BTT

Aktiekurs Baxter International Inc. i USDPUSH CHART

Kurs 50,49 USD 0,08 0,16 %
Kurstid 21:59:59
Datum 24.02.2017
Öppning 50,42
Gårdagen 50,49
Dagshögsta 50,56
Dagslägsta 50,24
52 v. högsta 50,70
52 v. lägsta 38,91
52 v. perf.
Volym (Antal) 178 485
Börsvärde (SEK) 247,32 Mrd
Börsen
Kurs för 50,49 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 456,27 SEK.

Till aktien Baxter International

Ticker
ISIN US0718131099
Index BX Swiss - USA, S&P 500, S&P 100, NYSE US 100

Baxter International Nyckeltal

Börsvärde i SEK 247,32 Mrd
Free float % 99,69
Antal aktier mio. 543,92
Cashflow/aktie i lokal valuta 2,28
Bokvärde/aktie i lokal valuta 17,02
60 dagar vola 28,28
PBV 2,56

Baxter International Historiska kurser

2017-02-23 50,41 78 118
2017-02-22 50,06 118 678
2017-02-21 49,96 228 121
2017-02-17 49,72 153 614
2017-02-16 49,42 104 937